Selective delivery of 5-fluorouracil (5-FU) to i.P. Tissues using 5-FU microspheres in rats

Anti-Cancer Drugs

Volumn 8, Issue 2, 1997, Pages 182-188

  Hagiwara, Akeo ^a   Sakakura, Chouhei ^a   Tsujimoto, Hiroyuki ^a   Imanishi, Tsutomu ^a   Ohgaki, Masaharu ^a   Yamasaki, Junya ^a   Sawai, Kiyoshi ^a   Takahashi, Toshio ^a   Fujita, Takuya ^b   Yamamoto, Akira ^b   Muranishi, Shozo ^b   Ikada, Yoshihito ^c  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; Animal experiments; Drug distribution; I.p. chemotherapy; Microspheres

Indexed keywords

FLUOROURACIL; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG TISSUE LEVEL; HEART; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG; MALE; MESENTERY; NONHUMAN; OMENTUM; PERITONEUM; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 8044242945     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199702000-00009     Document Type: Article

References (17)

1. Sugarbaker PH, Gianola FJ, Speyer JC, et al. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985; 98: 414-22.
2. Rusznyak I, Foldi M, Szabo G. Filtration and absorption through serous membranes. In: Youlten (ed.), Lymphatics and lymph circulation - physiology and pathology, 2nd edn. London: Pergamon Press 1967: 475-510.
3. Hagiwara A, Takahashi T, Shimotsuma M, et al. Development of 5-fluorouracil incorporated in microspheres for peritoneal carcinomatosis. Jpn J Cancer Cemother 1995; 22: 1638-40 (in Japanese with English summary).
4. Hagiwara A, Sakakura C, Takahashi T, et al. New formulation of 5-fluorouracil in microspheres reduces toxicity in mice. Anti-Cancer Drugs 1996; 7: 780-84.
5. Ogawa Y, Okada H, Yamamoto M, et al. In vivo release profiles of leuprolide acetate from microspheres prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers. Chem Pharmac Bull (Tokyo) 1988; 36: 2576-81.
6. Hagiwara A, Takahashi T, Sawai K, et al. Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice. Cancer Res 1993; 53: 687-92.
7. Jones RA, Buckpitt AR, Londer HH, et al. Potential clinical applications of a new method for quantitation of plasma levels of 5-fluorouracil and 5-fluorodeoxyuridine. Bull Cancer 1979; 66: 75-8.
8. Masuike T, Watanabe I, Takemoto Y. Quantitative method of 5-fluorouracil and its metabolites in biological samples using high performance liquid chromatography. Yakugaku Zasshi 1985; 105: 1058-64 (in Japanese with English summary).
9. Yamamoto K, Nakagawa T. A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers. J Pharmacobiodyn 1983; 6: 595-606.
10. Campra E, Esposito M, Civalleri D, et al. Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administration. Anticancer Res 1987; 7: 829-32.
11. Goldin A, Venditti JM, MacDonald JS, et al. Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute, Eur J Cancer 1981; 17: 129-42.
12. Curreri AR, Ansfield FJ, Mclver FA, et al Clinical studies with 5-fluorouracil. Cancer Res 1958; 18: 478-4.
13. Inaba M, Mitsubayashi J, Ozawa S. Kinetic analysis of 5-fluorouracil action against various cancer cells. Jpn J Cancer Res 1990; 81: 1039-44.
14. Jones RH, Myers CE, Guarino AM, et al. High volume intraperitoneal chemotherapy ('belly bath') for ovarian cancer Cancer Chemother Pharmacol 1978; 1: 161-6.
15. Speyer JL, Collins JM, Dedrick RL, et al. Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Res 1980; 40; 567-72.
16. Gyves JW, Ensminger WD, Stetson P, et al. Constant intraperitoneal 5-fluorouracil infusion through a totally implanted system. Clin pharmacol Ther 1984; 34: 83-9.
17. Mandache E, Negoescu A, Moldoveanu E. The development of lymphatic follicules in the omentum after intraperitoneal stimulation of rats. Morphol Embryol 1989; 35: 139-47.